Firefly Neuroscience, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Firefly Neuroscience, an AI-driven neuroscientific solutions company, has filed an S-1 registration statement for the resale of over 6 million common shares, while reporting substantial accumulated deficits and negative cash flows that raise significant doubt about its ability to continue as a going concern.
NASDAQ
S-1: Firefly Neuroscience Files for Resale of Up to 4.5 Million Shares Following Merger and New Financing
Firefly Neuroscience is registering for resale up to 4.5 million shares of its common stock, including shares issuable upon conversion of a convertible note, exercise of warrants, and potential sales under an equity line of credit agreement.
NASDAQ
Firefly Neuroscience, Inc. files an amendment to its registration statement, detailing the offering of over 2.5 million shares of common stock and underlying warrants.
NASDAQ
Firefly Neuroscience is registering for resale 2,559,645 shares of common stock by selling securityholders, including shares from private placements, warrant exercises, and conversions.
NASDAQ
Firefly Neuroscience, Inc. has filed an amended S-1 registration statement detailing the resale of common stock and warrants following its reverse merger with WaveDancer, Inc.
NASDAQ
Firefly Neuroscience registers for the resale of up to 2.56 million shares of common stock by selling securityholders following its recent reverse merger with WaveDancer.